INVESTMENTS - Schedule of statement of loss (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Operating expenses | ||||
| General and administrative expenses | $ 798 | $ 1,392 | $ 1,677 | $ 2,793 |
| Exploration and evaluation | 4,144 | 987 | 5,078 | 2,150 |
| Professional fees | 210 | 654 | 593 | 1,358 |
| Salaries & benefits | 416 | 540 | 777 | 1,035 |
| Travel | 10 | 19 | 24 | 62 |
| Interest expense | 161 | 12 | ||
| Fair value gain on derivative liability | 0 | 1,008 | 2,677 | 1,782 |
| Accretion expense | 363 | 0 | ||
| Net loss | (4,085) | (1,682) | (10,478) | (4,000) |
| Falcon Copper Corp ("FCC") [Member] | ||||
| Operating expenses | ||||
| General and administrative expenses | 300 | 72 | 641 | 94 |
| Exploration and evaluation | 1,398 | 24 | 1,474 | 99 |
| Professional fees | 2,556 | 283 | 4,483 | 855 |
| Salaries & benefits | 5,725 | 215 | 8,045 | 883 |
| Travel | 130 | 1 | 240 | 5 |
| Total operating expenses | 10,109 | 595 | 14,883 | 1,936 |
| Interest expense | 2 | 7 | 3 | 11 |
| Fair value gain on derivative liability | (3,498) | 0 | (641) | 0 |
| Other income | (98) | 0 | (138) | 0 |
| Accretion expense | 4,343 | 0 | 7,864 | 0 |
| Share of loss in associate | 75 | 0 | 110 | 0 |
| Net loss | $ 10,933 | $ 602 | $ 22,081 | $ 1,947 |
| X | ||||||||||
- Definition Represents amount of gain recorded on investment in associate. No definition available.
|
| X | ||||||||||
- Definition Mineral exploration expenditures No definition available.
|
| X | ||||||||||
- Definition Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Expenses incurred for travel and entertainment during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|